Navigation Links
Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program
Date:2/4/2008

Deal follows positive phase I data from novel product candidate AM103 for

the oral treatment of respiratory disease

SAN DIEGO, Feb. 4 /PRNewswire/ -- Amira Pharmaceuticals and GlaxoSmithKline today announced they have entered into a worldwide exclusive agreement to develop, manufacture and commercialize FLAP (5-Lipoxygenase Activating Protein ) inhibitors for the treatment of respiratory and cardiovascular disease.

Under the terms of the agreement GSK will be granted an exclusive, worldwide license to develop, manufacture and commercialize Amira's FLAP inhibitors, including AM103 and other compounds within the current development program. In the event that all potential development and regulatory milestones are successfully achieved, Amira could receive up to US $425 million in upfront and milestone payments. In addition, Amira will be entitled to receive tiered royalty payments based on worldwide net sales and commercial sales milestones.

Initial development activities will focus on candidate compound AM103, for the treatment of asthma. Positive data, from a phase I study completed in November 2007, show AM103 has the potential as a once-daily, oral, non-steroidal asthma treatment. In this study the compound was also well-tolerated.

Peppi Prasit, Chief Scientific Officer and Co-Founder Amira said: "To have identified such a positive drug candidate and progressed to the completion of phase I clinical trials just two years after the company was founded is a tremendous achievement for the team at Amira. We are delighted that GlaxoSmithKline will be taking this asset into full development. With their experience and expertise in this area we hope that AM103 will become the first FLAP inhibitor available to patients worldwide to treat symptoms of asthma and possibly other inflammatory diseases."

"This is a momentous day in the young life of Amira," said Bob Baltera, Chief Executive Officer, Amira. "This deal valid
'/>"/>

SOURCE Amira Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Amira Pharmaceuticals Appoints First Vice President of Development
2. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
3. Poniard Pharmaceuticals Announces Upcoming Conference Participation
4. Webcast Alert: Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results
5. Jazz Pharmaceuticals, Inc. Announces Submission of Complete Response to FDA Approvable Letter for LUVOX(R) CR
6. Acura Pharmaceuticals, Inc. Announces Approval to List Shares on NASDAQ and Effective Feb. 4, 2008 a New Trading Symbol: ACUR
7. Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors
8. Tibotec Pharmaceuticals a Respectful Partner to HIV Community in Pricing of Novel New HIV NNRTI, INTELENCE
9. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. MAP Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
11. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... (PRWEB) May 28, 2015 Dr. ... announced an exclusive deal to patients looking to undergo ... 1 through 30, patients will be able to get ... procedure, for just $600. For a three-treatment package, which ... treatment at no cost. , Dr. Juanita Jenyons, M.D., ...
(Date:5/28/2015)... 28, 2015 Are policies that spell ... hospital stay triggering financial pain for seniors? That’s what ... of Managed Care set to figure out, and its ... rule change. , The study, “Observation Encounters and Subsequent ... MD, MPH, examined how Medicare policies that distinguish between ...
(Date:5/28/2015)... 28, 2015 As the summer approaches, many ... cool. It’s important to make safety a top priority, however, ... swimming tips. , According to the Centers for Disease Control, ... States, not including boating incidents. Additionally, the National Safety Council ... ages 1 to 4. , Amica is sharing the ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Boston Celtics ... wife Beth, both Genesis Foundation Board of Directors members, ... Havlicek Celebrity Fishing Tournament June 4-7. For the past ... event benefitting The Genesis Foundation for children by bringing ... , The 34th John Havlicek Celebrity Fishing Tournament ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 The CEO ... announced a just launched blog series which provides analysis ... Hosted on the “R. Bruce Dalglish” profile on Blogger.com, ... R. Bruce Dalglish’s corporate experience. , “Throughout my ... workplace cultures have upon the overall success of businesses,” ...
Breaking Medicine News(10 mins):Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 2Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 3Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 2Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 3Health News:Splash! Amica Shares 6 Swimming Safety Tips 2Health News:The Genesis Foundation Prepares for Their Final Annual John Havlicek Celebrity Fishing Tournament 2Health News:R. Bruce Dalglish, CEO of Alliance Hospice, Introduces New Blog Series On Positive Corporate Culture 2
... A new fitness campaign for older Americans has been introduced by ... meant to encourage people 50 and older to become and stay ... for maintaining health and independence as people age, but regular physical ... to 64; 25 percent of those aged 65 to 74; and ...
... dementia have in common? Perhaps more than meets the eye, ... A diverse group of scientists experts in ... to study drugs that show promise in the treatment of ... heart failure. In this case, the connection between the head ...
... Wayne State University,s Parent Health Lab in the School ... identifies women at risk for drug use by evaluating ... itself. In phase I testing, this new screener proved ... detecting recent drug use. The team of researchers also ...
... in Spanish . Functional psychosis ... patient, thanks to affective symptomatology. Depressive moods, hyperactivity and ... themselves during the first psychotic episodes, and the presence ... differentiating, at an early stage, between the different variations ...
... COLUMBUS, Ohio Researchers at Ohio State University Medical Center ... to deliver a gene into the eyes of people born ... males. , The vector is part of a clinical ... a disease that affects an estimated 100,000 people worldwide. The ...
... Arbor, Mich. -- A University of Michigan Health System laboratory ... cells that could lead to a new treatment for those ... mice, appears in this week,s early edition of the ... promise for preventing the painful episodes and organ damage that ...
Cached Medicine News:Health News:Older Americans Encouraged to Get Fit 2Health News:Scientists explore whether what heals the head can also heal the heart 2Health News:Scientists explore whether what heals the head can also heal the heart 3Health News:Wayne State creating computer-based drug intervention for at-risk post-partum women 2Health News:Precise early diagnosis of psychotic disorders possible 2Health News:Ohio State researchers design a viral vector to treat a genetic form of blindness 2Health News:Researchers reveal potential treatment for sickle cell disease 2
(Date:5/28/2015)... AlloSource ®, one of the ... and soft-tissue allografts for use in surgical procedures ... announced that AlloWrap® DS, its double-sided human amniotic ... reimbursement category. "Reimbursement helps ensure ... said Kimberly French , Director of Marketing ...
(Date:5/28/2015)... 28, 2015 Research ... addition of the  "North America Ultrasound Devices ... - 2019)"  report to their offering.  ... is a type of imaging. It uses ... parts and structures inside the body. Health ...
(Date:5/28/2015)...   Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ... the Jefferies 2015 Healthcare Conference on Wednesday, June 3, ... New York .  Lexicon management will provide an ... A webcast of the presentation will be available ... version of the presentation will be available at ...
Breaking Medicine Technology:AlloSource Announces Milestone In Reimbursement For AlloWrap DS 2North America Ultrasound Devices Market Report 2014-2019 - Technology and Applications 2Lexicon To Present At The Jefferies 2015 Healthcare Conference 2
... Suffering from these Diseases, LOS ANGELES, March ... are two serious and debilitating,diseases with no confirmed ... new comprehensive literature study propose a simplified,treatment process ... these diseases., Kent Holtorf, M.D., medical director ...
... Data Presented at SIR Meeting Indicates New Catheter-based, ... Care for Treating Acute DVT, WASHINGTON, March ... the Society of Interventional Radiology,s 33rd Annual,Scientific Meeting ... from Bacchus Vascular, Inc. (Santa Clara, CA) successfully,breaks ...
Cached Medicine Technology:Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia 2Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia 3Trellis(R) Catheter Removes Blood Clots Quickly, Restoring Blood Flow in 771 Deep Vein Thrombosis (DVT) Patients 2
Cushing forceps. Insulated....
Scleral blades designed for trabeculectomy and groove type incisions, scleral standard USA size....
Fechtner Trabeculectomy Marker...
... when rotated at 8-10 rpm. Drums ... Light weight drum of professional quality ... mechanism. For use 24 to 30 ... and Pediatric Drums that can be ...
Medicine Products: